| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 943332-08-9 | Selumetinib sulfate(AZD6244 sulfate) |
≥98% | | 询价 |
| 2 | | Tanzisertib HCl(CC-930) |
≥98% | | 询价 |
| 3 | 899805-25-5 | Tanzisertib(CC-930) |
≥98% | | 询价 |
| 4 | 1454682-72-4 | LY3009120(DP-4978) |
≥98% | | 询价 |
| 5 | 1269440-17-6 | Encorafenib(LGX818) |
≥98% | | 询价 |
| 6 | 1188910-76-0 | Agerafenib(CEP-32496 RXDX-105 AC013773) |
≥98% | | 询价 |
| 7 | 1228591-30-7 | TAK-632 |
≥98% | | 询价 |
| 8 | 220904-83-6 | GW5074 |
≥98% | | 询价 |
| 9 | 284461-73-0 | Sorafenib(Bay 43-9006) |
≥98% | | 询价 |
| 10 | 208260-29-1 | ZM 336372 |
≥98% | | 询价 |
| 11 | 405554-55-4 | SB590885 |
≥98% | | 询价 |
| 12 | 940310-85-0 | NVP-BHG712(BHG712) |
≥98% | | 询价 |
| 13 | 878739-06-1 | AZ 628(AZ-628 AZ628) |
≥98% | | 询价 |
| 14 | 905281-76-7 | GDC-0879 |
≥98% | | 询价 |
| 15 | 1195765-45-7 | Dabrafenib(GSK2118436) |
≥98% | | 询价 |
| 16 | 923564-51-6 | ABT-263 |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 17 | 475207-59-1 | Sorafenib Tosylate(Bay 43-9006 Nexavar) |
≥98% | | 询价 |
| 18 | 918505-84-7 | PLX-4720 |
≥98% | | 询价 |
| 19 | 918504-65-1 | Vemurafenib(PLX4032 RG7204 RO5185426) |
≥98% | | 询价 |
| 20 | 464-92-6 | Asiatic Acid(Dammarolic acid,Asiantic acid) |
≥98% | | 询价 |
| 21 | 303162-79-0 | TAK-715 |
≥98% | | 询价 |
| 22 | 1221485-83-1 | Skepinone-L(CBS3830) |
≥98% | | 询价 |
| 23 | 284028-89-3 | XAV939 |
| 10mg, 25mg, 50mg, 100mg, 200mg | 询价 |
| 24 | 942183-80-4 | SCH772984 |
| 2mg, 5mg, 10mg, 50mg | 询价 |
| 25 | 585543-15-3 | Losmapimod(GW0856553X SB0856553) |
≥98% | | 询价 |
| 26 | 945614-12-0 | Pexmetinib(ARRY-614) |
≥98% | | 询价 |
| 27 | 193551-21-2 | SB239063 |
≥98% | | 询价 |
| 28 | 209410-46-8 | Neflamapimod(VX745,VRT031745 VD31745 |
≥98% | | 询价 |
| 29 | 58-58-2 | Puromycin dihydrochloride |
| 5mg, 10mg, 25mg | 询价 |
| 30 | 586379-66-0 | PH-797804 |
≥98% | | 询价 |
| 31 | 745833-23-2 | VX-702 |
≥98% | | 询价 |
| 32 | 862507-23-1 | Ralimetinib dimysylate(LY2228820 dimysylate) |
≥98% | | 询价 |
| 33 | 152121-30-7 | SB202190(FHPI) |
≥98% | | 询价 |
| 34 | 285983-48-4 | BIRB 796(Doramapimod) |
≥98% | | 询价 |
| 35 | 152121-47-6 | Adezmapimod(SB203580 RWJ-64809) |
≥98% | | 询价 |
| 36 | 22862-76-6 | Anisomycin(NSC-76712,AI 3-50846,Flagecidin,Wuningmeisu C) |
≥98% | | 询价 |
| 37 | 1809784-29-9 | DTP3 |
≥98% | | 询价 |
| 38 | 312917-14-9 | TCS JNK 5a |
≥98% | | 询价 |
| 39 | 1410880-22-6 | JNK-IN-8 |
≥98% | | 询价 |
| 40 | 129-56-6 | SP600125(SP600125 NSC75890) |
≥98% | | 询价 |
| 41 | 869886-67-9 | Ulixertinib(BVD-523 VRT752271) |
≥98% | | 询价 |
| 42 | 181223-80-3 | DEL-22379 |
≥98% | | 询价 |
| 43 | 896720-20-0 | VX-11e |
≥98% | | 询价 |
| 44 | 1435488-37-1 | XMD17-109 |
≥98% | | 询价 |
| 45 | 1453848-26-4 | Ravoxertinib(GDC-0994 RG-7842) |
≥98% | | 询价 |
| 46 | 865362-74-9 | FR 180204 |
≥98% | | 询价 |
| 47 | 1234480-50-2 | XMD8-92 |
≥98% | | 询价 |
| 48 | 942183-80-4 | SCH772984 |
≥98% | | 询价 |
| 49 | 923032-37-5 | Refametinib(RDEA119,BAY86-9766) |
≥98% | | 询价 |
| 50 | 391210-00-7 | PD318088 |
≥98% | | 询价 |
| 51 | 1035555-63-5 | TAK-733 |
≥98% | | 询价 |
| 52 | 869357-68-6 | AZD8330(ARRY704 ARRY424704) |
≥98% | | 询价 |
| 53 | 334949-59-6 | BIX 02188 |
≥98% | | 询价 |
| 54 | 305350-87-2 | SL-327 |
≥98% | | 询价 |
| 55 | 957054-30-7 | GDC-0941(Pictilisib) |
| 5mg, 10mg, 50mg, 200mg | 询价 |
| 56 | 252917-06-9 | CHIR-99021 |
| 2mg, 5mg, 10mg, 50mg, 100mg | 询价 |
| 57 | 1236699-92-5 | Pimasertib(SAR245509,AS703026,MSC1936369B) |
≥98% | | 询价 |
| 58 | 606143-89-9 | Binimetinib(Mektovi ARRY438162 ARRY162 MEK162) |
≥98% | | 询价 |
| 59 | 934660-93-2 | Cobimetinib(GDC-0973,RG-7420,XL-518) |
≥98% | | 询价 |
| 60 | 1168091-68-6 | GDC-0623(G-868) |
≥98% | | 询价 |
m.cnreagent.com